University of Dundee
- Country
- 🇬🇧United Kingdom
- Ownership
- Private
- Established
- 1967-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.dundee.ac.uk
Clinical Trials
113
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (91 trials with phase data)• Click on a phase to view related trials
Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes
- Conditions
- Heart FailureType 1 Diabetes
- Interventions
- Drug: Placebo
- First Posted Date
- 2024-05-30
- Last Posted Date
- 2025-08-21
- Lead Sponsor
- University of Dundee
- Target Recruit Count
- 320
- Registration Number
- NCT06435156
- Locations
- 🇬🇧
Ninewells Hospital, Dundee, United Kingdom
🇬🇧Royal Infirmary of Edinburgh, Edinburgh, United Kingdom
🇬🇧Glasgow Royal Infirmary, Glasgow Clinical Research Facility, Glasgow, United Kingdom
Bronchiectasis Alpha-1 Augmentation Trial- Modulating Airway Neutrophil Function
- Conditions
- Bronchiectasis Adult
- Interventions
- Drug: Alpha 1-Proteinase Inhibitor 180mg/kgDrug: Alpha 1-Proteinase Inhibitor 120mg/kg
- First Posted Date
- 2022-10-17
- Last Posted Date
- 2023-04-14
- Lead Sponsor
- University of Dundee
- Target Recruit Count
- 20
- Registration Number
- NCT05582798
- Locations
- 🇬🇧
NHS Tayside, Dundee, United Kingdom
STOP-COVID19: Superiority Trial Of Protease Inhibition in COVID-19
- First Posted Date
- 2021-03-26
- Last Posted Date
- 2023-08-22
- Lead Sponsor
- University of Dundee
- Target Recruit Count
- 406
- Registration Number
- NCT04817332
- Locations
- 🇬🇧
NHS Grampian, Aberdeen, United Kingdom
🇬🇧Royal United Hospitals Bath NHS Foundation Trust, Bath, United Kingdom
🇬🇧University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
Single Palatal Temporary Anchorage Device for Anterior Open Bite
- Conditions
- Anterior Openbite
- First Posted Date
- 2020-06-05
- Last Posted Date
- 2024-02-12
- Lead Sponsor
- University of Dundee
- Target Recruit Count
- 32
- Registration Number
- NCT04419805
- Locations
- 🇬🇧
Dundee Dental Hospital, Dundee, United Kingdom
Characterisation of the Time-course Response of UV-induced Erythema
- Conditions
- Erythema
- First Posted Date
- 2020-02-28
- Last Posted Date
- 2024-03-15
- Lead Sponsor
- University of Dundee
- Registration Number
- NCT04290273
- Prev
- 1
- 2
- 3
- 4
- 5
- 23
- Next
News
European Scientists Propose Alliance to Advance Proximity-Induced Drug Development for Undruggable Targets
Scientists from six leading European research institutions published a perspective in Molecular Cell proposing a European Alliance to accelerate development of proximity-induced drug modalities like PROTACs and molecular glue degraders.
£17.9 Million Wellcome Grant Funds Major Initiative to Combat Deadly Fungal Infections
A collaborative team from University of Dundee, GSK, and University of Exeter has received £17.9 million from Wellcome to develop new antifungal treatments over five years.